CompaniesExcelseBio

ExcelseBio

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

441

By Phase

PHASE2: 1PHASE3: 1

By Status

COMPLETED: 2NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT05413655
NCT06603285
Hover over trial bars to see details

Recent Trials

NCT06603285Lead Sponsor
A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin
N/ANot yet recruiting
20 participants
Started: Oct 16, 2025 · Completed: Dec 31, 2029
NCT05413655Lead Sponsor
A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease
PHASE2Recruiting
120 participants
Started: Aug 8, 2022 · Completed: Feb 28, 2027
NCT03299829Lead Sponsor
A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients
N/ACompleted
48 participants
Started: Jan 10, 2018 · Completed: Dec 30, 2019
NCT01725646Lead Sponsor
An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients
PHASE3Completed
253 participants
Started: Jul 31, 2011 · Completed: Aug 31, 2013